1 / 24

Frontier DermaSciences, LLC

Frontier DermaSciences, LLC. It’s not Rocket Science, It’s Smart Science. Joe Simiriglio Jr, President. $500,000. ($1.00 per Share) Day One: USE OF PROCEEDS. Represents __ Equity in Frontier DermaSciences, LLC

jake
Download Presentation

Frontier DermaSciences, LLC

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Frontier DermaSciences, LLC It’s not Rocket Science, It’s Smart Science. Joe Simiriglio Jr, President

  2. $500,000.($1.00 per Share) Day One: USE OF PROCEEDS • Represents __ Equity in Frontier DermaSciences, LLC • $125,000. Conducts Mini-Clinical Trial w/ 21 patients • $ 2,000. Oil Blend production for Mini-Clinical trial and samples to Physicians • $ 36,000. Operating Costs • $ 36,000. 1st yr Salary, Full-Time Operations, S. NJ TOTAL: $199,000. Does not include costs for any Professional Fees (Legal, Accounting), Product Liability Insurance, State Regulatory fees for Common Stock sale or issuance. Estimated costs at startup not more than $25,000.00

  3. Phase #2: Use of ProceedsWill be used once the Voluntary Mini-Clinical Trial is complete. • $ 36,000 Hire Inside Sales Person • $ 15,000 Part Time Production Employee • $ 50,000 Marketing, Tradeshows, Seminars Total: • $101,000 • Balance: $175,000 to $200,000 to ramp up production of product lines and marketing requirements for Psoriasis product.

  4. PROJECTED SALES2009 THRU 2014 YEAR SALES GROSS REV Net Profit % US POP 2009 0 0 0 0% 2010 $375,000 $318,750 $89,750 .25% 2011 $750,000 $673,500 $300,500 .50% 2012 $1,500,000 $1,275,000 $725,000 1.0% 2013 $3,000,000 $2,550,000 $1,670,000 2.0% 2014 $6,000,000 $4,000,000 $2,500,000 4.0% Estimated Operating Expenses: Management, Sales, Marketing & RMU’s, Outside Professional Services: Accounting, Legal, Liability & Employee Health Insurance, Outside Consultants, Board of Directors Expenses. 2010 $229,000 2011:$373,000 2012:$550,000 2013:$880,000 2014:$1,500,000 All financial figures are conservative, due to the consistent volume of “new” chronic psoriasis patients each year.

  5. 125 Million People… • 3% of the World’s population---suffer from psoriasis. A serious skin condition that can cause debilitating discomfort and distress,(125-million people). • 7.5 mm US citizens suffer from psoriasis • 100,000. Avg.new cases are identified each year in adults and children in USA.

  6. PSORIASIS • Psoriasis is a serious disease believed to be associated with an “auto-Immune defect” which sends the wrong signals to grow skin more rapidly in areas of the body where false damage to the skin may have occurred.

  7. $89,750. Net Profit • The Net Profit Projection after one full year of sales of Joe’s Soothing Psoriasis Skin Oil and treatment through Dermatologists. • Gross Sales $ 375,000. • Gross Profit $ 318,750. • The figures are specific to Psoriasis product sales only. • Projections are “Conservative.”

  8. 13,500 to 15,000 • Total membership in the American Association of Dermatologists 2008 • Just 1% or 135 Dermatologists promoting my treatment and oil blend to 120 Patients each, will result in first year treatment to 16,200 patients.

  9. Current Pharmaceutical Products Are Expensive. Each Drug requires continued treatment. There is a 40% to 60% success rate, where 75% to 85% of lesions disappear and reappear 8 to 10 months later requiring renewed use of drugs listed below. Long term treatment with drugs listed all have adverse side effects. Death has occurred with one of the drugs listed below, another has a Black Label Warning. • CURRENT UNINSURED COST PER PATIENT • Enbrel AMGEN $12,000 + PER YR • Raptiva GENENTECH $10 TO 25,000 PER YR • Humira ABBOT LABS $13,000 PER YR • Remicade CENTOCOR (J & J) $12 TO 25,000 PER YR Each have severe side effect warnings TOPICAL PRESCRIPTION STEROID PRODUCTS: Various Pharma Talconex, Dovonex, Tazorac, Salex, Olux, Neoral, Derma-Smooth, Temovate.

  10. $1,685. Phase #1: Patient Cost • Initial estimated “Uninsured” patient cost, does not include cost of office visits with a minimum of three months treatment to a maximum of six months treatment in any year of treatment. • No treatment of patient is performed June through September.

  11. My Back 12Jan09. Lower back (ctr), Hip straight across Psoriasis & up my spine to shoulders. 25% of original Psoriasis returned after non-treatment for first 10-months of 2008. Prior to any treatment, my entire back shoulder to shoulder to buttocks, hip to hip was covered with psoriasis lesions.

  12. Psoriasis: 12Jan09, Left lower Leg • My Psoriasis was untreated most of 2008. It returned Sept 2008. • I took SORIATANE not more than 1x / day per week starting Sept. • I applied my Oil blend not more than three days / week, evening. • My non-treatment was intentional • Only 25% of the Psoriasis returned to my entire body, • Majority of the resurgent Psoriasis appeared on my back and legs. • Prior to treatment my entire calf from knee to ankle on both sides were marked with Psoriasis on both legs.

  13. Psoriasis-Upper Left Leg Photo taken 12Jan09 Upper Left Leg. Both legs had lesions in a oval shape at 9” x 4” This photo displays only a very small lesion (Just about visible) no treatment in a tanning salon in 2008. Treated only with Soriatane and my Oil blend.

  14. Psoriasis Photo Taken on 11Feb09 • Photo of my Back shows psoriasis lesions are now gone. The white areas in the photo were the lesions prior 12Jan09 (one month) • The skin is hydrated, smooth and even with the surrounding area. • Session #2 tanning booth will begin 24Feb09: 8-minutes for 5-sessions, 9-minutes for 5-sessions, 10-minutes per session to 3/24/09.

  15. Psoriasis Photo of Left Calf 11Feb09 • Compare photo of 12Jan09 to 11Feb09. You will notice a major reduction of psoriasis lesions. • Lesions still present will be gone by end of Treatment Session #2 between 24Feb to 24March09. • Very small lesions are seen below the knee.

  16. Psoriasis Photo of Upper Left Leg11Feb09 • The psoriasis lesions visible on 12Jan09, is 95% eliminated. with 1 more month of treatment, it will be 100% eliminated. • My mid-to-severe case is now mild. • Psoriasis has not returned in many areas. No new lesions have appeared since I began my experiment. • My only side effect is a Miami tan. • My quality of life is much better and I don’t mind taking my shirt off at the beach. • I don’t miss the embarrassing comments of strangers.

  17. SESSION STATISTICS 1/12 TO 2/11/09DISPLAYS SESSIONS/MINUTES USED TO ACHIEVE REDUCTION IN PSORIASIS LESIONS AS VIEWED IN ALL PHOTOGRAPHS • TOTAL TANNING BOOTH SESSIONS: 18 • TIME SESSIONS SEQUENCE: • 2- FIVE MINUTE SESSIONS • 4- SIX MINUTE SESSIONS • 4- SEVEN MINUTE SESSIONS • 4- EIGHT MINUTE SESSIONS • 4-TEN MINUTE SESSIONS • ALL SESSIONS BEGINNING 2/24/09 Will be 8,9, & 10 minute sessions ending 3/26/2009. • 17-Total Soriatane Capsules (25mg) • 25-Soriatane Capsules taken 12/08/2008 to 1/12/2009 prior to tanning sessions. • TOTAL MINUTES: 134 (2.23 Hrs) stand up tanning booth • Each patient will have a custom treatment program based on their skin type, age, weight and all other factors routinely taken into consideration by their physician.

  18. Other Products Ready for Market I have developed from my original invention two additional products: • Joe’s Caribe “0” SPF Tanning Oil-End of 4th QTR 2009 • “U” for Unisex Pre-Shave Oil-Beginning of 1st QTR 2010 • Both products can be sold OTC and in many markets. Both products would compete in very competitive markets. • Both products can sell in Mass Retail andin boutique markets, • Both Products can be Private Labeled, Licensed, and co-exist with a major retailer on the same shelf.

  19. Session Statistics 2/24 to 3/26/09This page displays sessions/minutes in a Stand-Up Tanning Booth like all previous sessions at a local Deptford, NJ Hollywood Tanning Salon, Unit HT54 High. Photographs to follow on slides will show only three-psoriasis spots are visible. • Total Tanning Booth Sessions: 24 • 7- Eight Minute sessions • 8-Nine Minute sessions • 9-Ten Minute sessions • 16- Soriatane Capsules (25mg) taken • Total Tanning time: 218 minutes (3.63 hours) • Photographs will show elimination of all but three white spots which are the last of my Psoriasis. • I will add an additional tanning session for one more month. • In this last session I will not take any Soriatane and will only use my Blended Oil product. The result will be 100% clearance of all remaining psoriasis. I am available to be physically observed.

  20. Photo taken on 3/31/2009Photograph will show 100% clearance. The White Reflective area is the location of where the psoriasis once was. On my final tanning session of the year. My skin color will blend in and the white area will be eliminated. • If you view the photo and look to the left side of the neck/shoulder area you will see one small white spot. That is the only Psoriasis on my back. There are no more lesions.

  21. Photograph taken 3/31/2009This photograph displays my left calf. Their only remains one psoriasis spot that is nearly flat, the entire calf is 100% clear of any psoriasis • The Left Calf had psoriasis. While the Right Calf was 100% clear. There is only one-spot on my calf and it will be eliminated in my final tanning/oil blend only treatment. No Soriatane will be taken in the last stage of my testing and treatment for 2009.

  22. Photograph taken on 3/31/2009The photograph of my Thigh area where a small circular psoriasis lesions had formed after 9-10 months of no treatment in 2008, has been 100% eliminated. The area is 100% declared “CLEAR!” • Upon reviewing my slides and my photographs, Your probably thinking this cannot be, How can a natural product, a Tanning booth group of sessions and the use of a drug “Soriatane” wipe out and control psoriasis. For the Scientific community, I ask that you observe and think “Beyond the Box” that you are accustomed too. Science is ever-evolving, Throw out the books and open your mind to the possibility that natural products, along with technology can solve certain skin care issues. • PHOTO-THERAPY WORKS-PTW IS SAFE • I am proof that my product-treatment is much safer than products made by • AMGEN, • GENENTECH, • ABBOTT • J & J CENTOCOR • My product-treatment can improve the condition of psoriasis at a much less cost and non-invasive treatment.

  23. RAPTIVA WARNING. • Raptiva (efalizumab) • Audience: Dermatological healthcare professionals, patients Genentech and FDA notified healthcare professio nals of the voluntary, phased withdrawal of Raptiva, a medication for treatment of psoriasis, from the U.S. market due to a potential risk to patients of developing progressive multifocal leukoencephalopathy (PML). By June 8, 2009, Raptiva will no longer be available in the United States. Prescribers are being asked not to initiate Raptiva treatment for any new patients. Prescribers should immediately begin discussing with patients currently using Raptiva how to transition to alternative therapies. The FDA strongly recommends that patients work with their health care professional to transition to alternative therapies for psoriasis. • Read the complete MedWatch 2009 Safety Summary, including links to the Dear Healthcare Professional letter, the Dear Patient letter and the FDA statement, at: http://www.fda.gov/medwatch/safety/2009/safety09.htm#Raptiva • You are encouraged to report all serious adverse events and product quality problems to FDA MedWatch at www.fda.gov/medwatch/report.htm Update your subscriptions, modify your e-mail address, or stop subscriptions at any time on your Subscriber Preferences Page. You will need to use your e-mail address to log in. If you have questions or problems with the subscription service, please contact support@govdelivery.com. • This service is provided to you at no charge by U.S. Food & Drug Administration (FDA). • GovDelivery, Inc. sending on behalf of U.S. Food & Drug Administration (FDA) · 5600 Fishers Lane · Rockville MD 20857 · 800-439-1420 • GovDelivery, Inc. sending on behalf of U.S. Food & Drug Administration (FDA) · 5600 Fishers Lane · Rockvill

  24. Frontier DermaSciences, LLC Summary I bring to the marketplace a product that doesn’t have any side effects of the magnitude presented by Humira, Raptiva, Enbrel, and Remicade. The Product treatment is simple, affordable for the psoriasis condition and extremely safe. The patient can eventually treat themselves with only maintenance visits to their doctor. The patient can order a Home Photo-Therapy unit from at least 6-manufacturers and the up to 80% of the units are paid for by their insurance company. The marketplace has consistant volume. Our target is 4% market penetration by 2014 or sooner. I am confident once the word gets out by patients my product and treatment will be sought out by the larger cosmetic and pharmaceutical companies around the globe. The Opportunity Exit Strategy Is for “First Round Investors” • Direct Purchase of Frontier by a mid to major cosmetic or pharma Co. • Licensing Frontier’s formula. • Co-Marketing Frontier’s products nationally & globally Louie Pasteur had his magic bullet, I have my blended oils. The Patient will feel the difference. My Power Point Presentation was originally given before an Angels Investors Group based in Princeton New Jersey. My PPP has evolved and has been updated as work on my PSORIASIS Product continues.

More Related